[1]Jin B, Dong P, Li K, et al. Meta-analysis of the association between GSTT1 null genotype and risk of nasopharyngeal carcinoma in Chinese[J]. Tumour Biol, 2014, 35(1): 345-349.
[2]Safavi A, Raad N, Raad N, et al. Epidemiology of nasopharyngeal cancers in Iran: Aa 6-year report [J]. Asian Pac J Cancer Prev, 2015, 16(10): 4447-4450.
[3]Tortorella SM, Royce SG, Licciardi PV, et al. Dietary sulforaphane in cancer chemoprevention: the role of epigenetic regulation and HDAC inhibition [J]. Antioxid Redox Signal, 2015, 22(16): 1382-1424.
[4]Nallasamy P, Si H, Babu PV, et al. Sulforaphane reduces vascular inflammation in mice and prevents TNF-α-induced monocyte adhesion to primary endothelial cells through interfering with the NF-κB pathway[J]. J Nutr Biochem, 2014, 25(8): 824-833.
[5]Li B, Kim DS, Yadav RK, et al. Sulforaphane prevents doxorubicin-induced oxidative stress and cell death in rat H9c2 cells[J]. Int J Mol Med, 2015, 36(1): 53-64.
[6]Park JH, Kim JW, Lee CM,et al. Sulforaphane inhibits the Th2 immune response in ovalbumin-induced asthma[J]. BMB Rep, 2012, 45(5): 311-316.
[7]Wu CC, Chuang HY, Lin CY, et al. Inhibition of Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane[J]. Mol Carcinog, 2013, 52(12): 946-958.
[8]Li X, Zhao Z, Li M, et al. Sulforaphane promotes apoptosis, and inhibits proliferation and self-renewal of nasopharyngeal cancer cells by targeting STAT signal through miRNA-124-3p[J]. Biomed Pharmacother, 2018, 103(12): 473-481.
[9]杨柳, 李昕. AKt /mTOR信号通路中p70S6K1、4E-BPs在促进肿瘤发生作用中的研究进展[J]. 现代肿瘤学, 2016, 24(5): 847-850.
[10]Wang W, Wen Q, Xu L, et al. Activation of Akt/mTOR pathway is associated with poor prognosis of nasopharyngeal carcinoma [J]. PLoS One, 2014, 9(8): e106098.
[11]Wang L, Tian Z, Yang Q, et al. Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway [J]. Oncotarget, 2015, 6(28): 25917-25931.
[12]Bauman JE, Zang Y, Sen M, et al. Prevention of carcinogen-induced oral cancer by sulforaphane [J]. Cancer Prev Res (Phila), 2016, 9(7): 547-557.
[13]Agliarulo I, Matassa DS, Amoroso MR, et al. TRAP1 controls cell migration of cancer cells in metabolic stress conditions: Correlations with AKT/p70S6K pathways [J]. Biochim Biophys Acta, 2015, 1853(10): 2570-2579.
[14]Sangawa A, Shintani M, Yamao N, et al. Phosphorylation status of Akt and caspase-9 in gastric and colorectal carcinomas[J]. Int J Clin Exp Pathol, 2014, 7(6): 3312-3317.
[15]Wu Q, Zhao QN, Song WD. The research and progress of PI3K/ Akt /mTOR signal transduction pathway in tumors [J]. J Dis Control, 2013, 7(6): 346-347.
[16]Li GB, Shan CY, Liu L, et al. Tanshinone IIA inhibits HIF-1α and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6 /4E-BP1 signaling pathway[J]. PLoS One, 2015, 10(2): e0117440.
[17]Li X, Zhao Z, Li M, et al. Sulforaphane promotes apoptosis, and inhibits proliferation and self-renewal of nasopharyngeal cancer cells by targeting STAT signal through miRNA-124-3p[J]. Biomed Pharmacother, 2018, 103(8): 473-481. |